Medical Management of Gastroesophageal Reflux Disease

被引:23
作者
Wang, Changcheng [1 ]
Hunt, Richard H. [1 ]
机构
[1] McMaster Univ, Hlth Sci Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada
关键词
Gastroesophageal reflux disease (GERD); Proton pump inhibitors (PPIs); Antisecretory therapy; Antireflux surgery;
D O I
10.1016/j.gtc.2008.09.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Antisecretory therapies that raise intragastric pH provide the best healing of the esophageal mucosal damage that occurs in gastroesophageal reflux disease. Continuous maintenance therapy is also effective to reduce the likelihood of recurrence of esophagitis and control symptoms in the long term. Proton pump inhibitor (PPI) therapy is an effective approach for healing esophagitis and controlling symptoms. Endoscopic and surgical treatments may provide an option for patients who are refractory to PPIs in whom reflux has been clearly demonstrated. Long-term antireflux medication is often needed after surgical treatment because of persisting or recurrent pathologic reflux and symptoms. An alternative approach to controlling transient lower esophageal sphincter relaxations, such as the GABA-B agonists, deserves further study.
引用
收藏
页码:879 / +
页数:22
相关论文
共 130 条
[11]   Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease [J].
Caviglia, R. ;
Ribolsi, M. ;
Gentile, M. ;
Rabitti, C. ;
Emerenziani, S. ;
Guarino, M. P. L. ;
Petitti, T. ;
Cicala, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (05) :629-636
[12]   Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure [J].
Caviglia, R ;
Ribolsi, M ;
Maggiano, N ;
Gabbrielli, AM ;
Emerenziani, S ;
Guarino, MPL ;
Carotti, S ;
Habib, FI ;
Rabitti, C ;
Cicala, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03) :543-548
[13]   Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults [J].
Chang, A. B. ;
Lasserson, T. J. ;
Gaffney, J. ;
Connor, F. L. ;
Garske, L. A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04)
[14]   The role of esophageal pH monitoring in symptomatic patients on PPI therapy [J].
Charbel, S ;
Khandwala, F ;
Vaezi, MF .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (02) :283-289
[15]  
Chey WD, 2008, GASTROENTEROLOGY, V134, pA323
[16]   Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease [J].
Ciccaglione, AF ;
Marzio, L .
GUT, 2003, 52 (04) :464-470
[17]  
Coron E, 2007, CURR OPIN GASTROEN, V23, P434
[18]   The burden of illness of gastro-oesophageal reflux disease: impact on work productivity [J].
Dean, BB ;
Crawley, JA ;
Schmitt, CM ;
Wong, J ;
Ofman, JJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (10) :1309-1317
[19]   Effectiveness of Proton Pump Inhibitors in Nonerosive Reflux Disease [J].
Dean, Bonnie B. ;
Gano, Anacleto D., Jr. ;
Knight, Kevin ;
Ofman, Joshua J. ;
Fass, Ronnie .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) :656-664
[20]  
Delhotal-Landes B, 1991, Eur J Drug Metab Pharmacokinet, VSpec No 3, P315